Metabolomika jako potencjalna metoda diagnostyczna w medycynie

• Autorzy: Ząbek A. , Młynarz P.
• Języki publikacji: PL

Słowa kluczowe

PL

metabolomika; diagnostyka medyczna; metabolityka; profil metaboliczny

EN

metabolomics; medical diagnosis; metabonomics; metabolism profile

• Wydawca: Roble Sp. z o.o.
• Czasopismo: LAB Laboratoria, Aparatura, Badania
• Rocznik: 2012
• Tom: R. 17, nr 2
• Strony: 20--26
• Opis fizyczny: Bibliogr. 36 poz.

Twórcy

autor

Ząbek A.

autor

Młynarz P.

• Zakład Chemii Bioorganicznej, Politechnika Wrocławska

Bibliografia

• [1] Kraj A., Drabik A., Silberring J., Proteomika i metabolomika, Wydawnictwo Uniwersytetu Warszawskiego, 2010
• [2] Greef J., Smilde A. K., Symbiosis of chemometrics and metabolomics: past, present, and future, J. Chemometrics, 2005, 19: 376-386
• [3] Dembińska-Kieć A., Nastalski J.W., "Diagnostyka laboratoryjna z elementami biochemii klinicznej. Podręcznik dla studentów medycyny", Elsevier Urban & Partner, Wrocław 2009
• [4] Chorąży M., Wprowadzenie do biologii systemów, NAUKA, 2011, 59-84
• [5] Nordström A., Lewensohn R., Metabolomics: moving to the clinic, J. Neuroimmune Pharmacol, 2010, 5:4-17
• [6] Wishart D. S., Tzur D., Knox C., Eisner R., Guo A. C., Young N., Cheng D., Jewell K., Arndt D., Sawhney S., Fung C., Nikolai L., Lewis M., Coutouly M. A., Forsythe I., Tang P., Shrivastava S., Jeroncic K., Stothard P., Amegbey G., Block D., Hau D. D., Wagner J., Miniaci J., Clements M., Gebremedhin M., Guo N., Zhang Y., Duggan G. E., Macinnis G. D., Weljie A. M., Dowlatabadi R., Bamforth F., Clive D., Greiner R., Li L., Marrie T., Sykes B. D., Vogel H. J., Querengesser L., HMDB: the Human Metabolome Database, Nucleic Acids Research, 2007, Vol. 35
• [7] Beckonert O., Keun H. C., Ebbels T. M. D., Bundy J., Holmes E., Lindon J. C., Nicholson J. K., Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma serum and tissue extracts, Nature Protocols, 2007, Vol. 2
• [8] Bothwell J. H. F., Griffin J. L., An introduction to biological nuclear magnetic resonance spectroscopy, Biological Reviews, 2010
• [9] Lei Z., Huhman D. V., Sumner W. L., Mass spectrometry strategies in metabolomics, The Journal of biological chemistry, 2011, Vol. 286
• [10] Dettmer K., Aronov P. A., Hammock B. D., Mass spectrometry- based metabolomics, Mass Spectrometry Reviews, 2007
• [11] Villas-Bo^as S. G., Mas S., A °kesson M., Smedsgaard J., Nielsen J., Mass spectrometry in metabolome analysis, Mass spectrometry reviews, 2005, Vol. 24
• [12] Becker S., Kortz L., Helmschrodt C., Thiery J., Ceglarek U., LC-MS-based metabolomics in the clinical laboratory, Journal of Chromatography B, 883- 884, 2012, 68- 75
• [13] Metz T.O., Metabolic Profiling, Springer Science+Business Media, LLC 2011
• [14] Trygg J., Holmes E., Lundstedt T., Chemometrics in Metabonomics, Journal of proteome research, 2007, 6, 469-479
• [15] Holmes E., Nicholls A. W., Lindon J. C., Connor S. C., Connelly J. C., Haselden J. N., Damment S. J., Spraul M., Neidig P., Nicholson J. K., Chemometric models for toxicity classification based on NMR spectra of biofluids, Chem. Res. Toxicol., 2000, 13, 471-478
• [16] Gramacki J., Gramacki A., Wybrane metody redukcji wymiarowości danych oraz ich wizualizacji, XIV Konferencja PLOUG Szczyrk, 2008
• [17] Bylesjo M., Rantalainen M., Cloarec O,, Nicholson J, K, Holmes E., Trygg J., OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification, Journal of Chemometrics, 2007, 20, 341-351
• [18] Trygg J., Svante W., Orthogonal projections to latent structures (O-PLS), Journal of Chemometrics, 2002, 16, 119-128
• [19] Kosliński P., Bujak R., Daghir E., Markuszewski M. J., Metabolic profiling of pteridines for determination of potential biomarkers in cancer disease, 2011, Electrophoresis, 32, 2044-2054
• [20] Zhang Z., Qiu Y., Hua Y., Wang Y., Chen T., Zhao A., Chi Y., Pan L., Hu S., Li J., Yang C., Li G., Sun W., Cai Z., Jia W., Serum and urinary metabonomic study of human osteosarcoma, Journal of proteome research, 2010, 9, 4861-4868
• [21] Nam H., Chung B. C., Kim Y., Lee KY., Lee D, Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification, Bioinformatics, 2009, 25, 3151-3157
• [22] Asiago V. M., Alvarado L. Z., Shanaiah N., Gowda G. A. N., Owusutu-Sarfo K., Ballas R. A., Raftery D., Early detection of recurrent breast cancer using metabolite profiling, Cancer research, 2010, 70, 8309-8318
• [23] Issaq H. J., Fox S. D., Chan K. C., Veenstra T. D., Global proteomics and metabolomics in cancer biomarker discovery, Journal of Separation Science, 2011, 34, 3484-3492
• [24] Wen H., Soo Yoo S., Kang J., Kim H. G., Park J-S., Jeon S., Lee J. I., Kwon H., N., Kang S., Lee D-H., Park S., A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer, Journal of hepatology, 2010, 52, 228-233
• [25] Yi Ng D. J., Pasikanti K. K., Yong Chan E. C., Trend analysis of metabonomics and systematic review of metabonomics- derived cancer marker metabolites, Metabolomics, 2011, 7, 155-178
• [26] Caudle W. M. Bammer T. K., Lin Y., Pan S., Zhang J., Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease, Expert Rev Neurother, 2011, 10, 925-942
• [27] Barba I, Fernandez- Montesinos R., Garcia-Dorado D., Pozo D., Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy- based metabolomics, Journal of cellular and molecular medicine, 2008, 12, 1477-1485
• [28] Holmes E., Tsang T. M., Tabrizi S. J., The application of NMR-based metabonomics in neurological disorders, NeuroRx, 2006, 3, 358-372
• [29] Greenberg N., Grassano A., Thambisetty M., Lovestone S., Legido-Quigley C., A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease, Electrophoresis, 2009, 30, 1235-1239
• [30] Rozen S., Cudkowicz M. E., Bogdanov M., Matson W. R., Kristal B. S., Beecher C., Harrison S., Vouros P., Flarakos J., Vigneau-Callahan K., Matson T. D., Newhall K. M., Beal M. F., Brown R. H., Kaddurah-Daouk R., Metabolomic analysis and signatures in motor neuron disease, Metabolomics, 2005, Vol. 1
• [31] Kumar A., Bala L., Kalita J., Misra U. K., Singh R. L., Khetrapal C. L., Babu G. N.,, Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis, Clinica Chimica Acta, 2010, Vol. 411
• [32] Prabakaran S., Swatton J. E., Ryan M.M., Huffaker S. J., Huang Jt-J., Griffin J. L., Wayland M., Freeman T., Dud- bridge F., Lilley K. S., Karp N. A., Hester S., Tkachev D., Mimmack M. L., Yolken R. H., Webster M. J., Torrey E. F., Bahn S., Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress, Molecular Psychiatry, 2004, Vol. 9
• [33] Orešič M., Tang J., Seppänen- Laakso T., Mattila I., Saarni S. E., Saarni S. I., Lönnqvist J., Sysi-Aho M., Hyötyläinen T., Perälä J., Suvisaari J., Metabolome in schizophrenia and other psychotic disorders: a general population-based study, Genome Medicine, 2011, Vol. 3
• [34] Holmes E., Tsang Tsz. M., Huang J. T-J., Leweke F. M., Koethe D., Gerth C. W., Nolden B. M., Gross S., Schreiber D., Nicholson J. K., Bahn S., Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia, PLoS medicine, 2006, Vol. 3
• [35] WeissR. H., Kim K., Metabolomics in the study of kidney disease, Nature reviews. Nephrology, 2012, 8, 22-33
• [36] Boudonck K. J., Mitchell M. W., Nemet L., Keresztes L., Nyska A., Shinar D., Rosen- stock M., Discovery of metabolomics biomarkers for early detection of nephrotoxicity, Toxicologic Pathology, 2009, 37, 280-292